Picton Mahoney Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Picton Mahoney Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.4M	Buy	925,408 +115,190	+14%	+$3.84M	0.23%	78
2026 Q1	$24.4M	Buy	810,218 +229,467	+40%	+$7.38M	0.18%	95
2025 Q4	$18.1M	Sell	580,751 -37,141	-6%	-$915K	0.14%	128
2025 Q3	$12.5M	Sell	617,892 -96,721	-14%	-$1.7M	0.11%	164
2025 Q2	$12M	Buy	714,613 +117,756	+20%	+$1.9M	0.12%	163
2025 Q1	$9.17M	Sell	596,857 -36,292	-6%	-$648K	0.16%	139
2024 Q4	$14M	Buy	633,149 +213,041	+51%	+$3.88M	0.28%	83
2024 Q3	$7.57M	Buy	420,108 +221,608	+112%	+$3.88M	0.25%	125
2024 Q2	$3.23M	Buy	+198,500	New	+$3.06M	0.13%	182
2017 Q1	–	Sell	-14,100	Closed	-$510K	–	225
2016 Q4	$510K	Hold	14,100	–	–	0.04%	155
2016 Q3	$648K	Sell	14,100 -62,050	-81%	-$3.24M	0.04%	185
2016 Q2	$3.83M	Sell	76,150 -41,740	-35%	-$2.22M	0.24%	112
2016 Q1	$6.31M	Sell	117,890 -8,169	-6%	-$479K	0.4%	85
2015 Q4	$8.28M	Buy	126,059 +74,359	+144%	+$4.6M	0.49%	74
2015 Q3	$2.92M	Buy	+51,700	New	+$3.35M	0.17%	118
2013 Q3	–	Sell	-76,900	Closed	-$3.02M	–	365
2013 Q2	$3.02M	Buy	+76,900	New	+$2.99M	0.22%	112

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Picton Mahoney Asset Management's TEVA Position: Q2 2026 in Review

Picton Mahoney Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 14% in Q2 2026, buying an estimated $3.84M and bringing the position to 925,408 shares worth $31.4M. The position accounts for 0.23% of the portfolio, ranked #78.

Picton Mahoney Asset Management first reported a position in TEVA in Q2 2013 and has held it in 16 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Picton Mahoney Asset Management held 925,408 shares of Teva Pharmaceuticals worth $31.4M as of Q2 2026.
Picton Mahoney Asset Management bought 115,190 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.84M.
Teva Pharmaceuticals made up 0.23% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #78 holding.
Picton Mahoney Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.